The JAK-STAT pathway is critical in ventilator-induced diaphragm dysfunction

Area of Science:

• Critical Care Medicine
• Molecular Biology
• Physiology

Background:

• Mechanical ventilation (MV) is crucial for critically ill patients but can cause ventilation-induced diaphragm dysfunction (VIDD).
• Oxidative stress is implicated in VIDD, but its regulatory mechanisms are unclear.
• The JAK-STAT pathway's role in diaphragm function during MV is not well understood.

Purpose of the Study:

• To investigate the role of the JAK-STAT pathway in the pathogenesis of VIDD.
• To determine if JAK-STAT activation contributes to oxidative stress and mitochondrial dysfunction in ventilated diaphragm muscle.
• To evaluate the therapeutic potential of JAK-STAT inhibition for preventing VIDD.

Main Methods:

• Analysis of JAK-STAT pathway activation (phosphorylation) in human diaphragm samples from MV patients.
• Utilizing a rat model of MV to assess diaphragm contractile function and mitochondrial health.
• Employing JAK inhibitors to block the JAK-STAT pathway in vivo and in cultured muscle cells.

Main Results:

• The JAK-STAT pathway is significantly activated in the human diaphragm during MV.
• JAK-STAT inhibition in a rat MV model prevented diaphragm muscle contractile dysfunction by approximately 85%.
• Activated STAT3 was found to impair mitochondrial function and induce oxidative stress, with oxidative stress also activating JAK-STAT.

Conclusions:

• JAK-STAT pathway activation is a critical regulator of oxidative stress in ventilated diaphragm muscle.
• This pathway is central to the pathogenesis of clinical VIDD.
• JAK-STAT inhibitors show therapeutic promise for ventilated ICU patients to prevent diaphragm dysfunction.